>全球帕陶综合征市场，按诊断（超声波、无细胞 DNA 筛查、妊娠相关血浆蛋白 A 筛查）、治疗（手术和疗法）、最终用户（医院、研究机构、专科诊所）、分销渠道（医院药房、零售药房、网上药房和其他）划分 - 行业趋势和预测到 2029 年。
帕陶综合征市场分析和规模
帕陶综合征是常染色体三体性中最为罕见和最严重的疾病之一。患者的平均生存期不到 3 天。每 5,000 个新生儿中，约有 1 个患有帕陶综合征。此外，母亲年龄越大，婴儿患此综合征的风险就越大。超过 90% 患有帕陶综合征的婴儿在出生后第一年内死亡。关于帕陶综合征的诊断，细胞遗传学分析是产前诊断该综合征的重要步骤。据观察，患者通常肌肉张力低，因此看起来非常灵活，但实际上由于这种虚弱加上骨骼脆弱，导致他们缺乏力量，经常发生骨折。
Data Bridge Market Research 分析了 2022-2029 年预测期内全球帕陶综合征市场的增长率。在上述预测期内，全球帕陶综合征市场的预期复合年增长率往往在 25% 左右。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。
帕陶综合征市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制为 2014 - 2019） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
诊断（超声波、无细胞 DNA 筛查、妊娠相关血浆蛋白 A 筛查）、治疗（手术和疗法）、最终用户（医院、研究机构、专科诊所）、分销渠道（医院药房、零售药房、网上药房和其他） |
|
覆盖国家 |
北美洲的美国、加拿大和墨西哥、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲其他地区 |
|
涵盖的市场参与者 |
Centogene N.V. (Germany), Eurofins Discovery (Luxembourg), Hoffmann-La Roche Ltd. (Switzerland), Invitae Corporation (U.S.), LLumina Inc (U.S.), Natera Inc (U.S.), PerkinElmer Inc (U.S.), Quest Diagnostics Incorporated (U.S.), Eurofins LifeCodexx GmbH (Germany), Ravgen (U.S.) |
|
Market Opportunities |
|
Market Definition
Patau syndrome is a rare genetic disorder that occurs when there are extra chromosomes in the cells of the body. This disorder results from the presence of three, instead of the normal two, copies of chromosome 13 (trisomy). This syndrome includes symptoms such as intellectual disabilities or developmental delays, heart defects, neurological disorders such as seizures, or hyperactivity problems that affect behavior or learning ability among others.
Global Patau Syndrome Market Dynamics
Drivers
- Increasing Prevalence of Patau Syndrome
The rising incidence of patau syndrome is boosting the growth of the market. Patau's syndrome affects about 1 in every 5,000 births. With the passing age, the risk of having a baby with the syndrome increases. More than 9 out of 10 children born with patau syndrome die during the first year. Around 1 in 10 babies witnessing less severe forms of the syndrome, such as partial or mosaic trisomy 13, live for more than a year. Thus, it acts as a major driver in the market growth.
- Increase in the number of research and development activities
Moreover, the market's growth is fueled by the rise in the number of research and development activities. This will provide beneficial opportunities for the global patau syndrome market. To encourage researchers and pharmaceutical companies to develop novel medicines, the government is funding research and development (R&D) initiatives.
Opportunities
- Increased Demands of Diagnostic Tests
Different kinds of diagnostic procedures are helping to create opportunities of the global patau Syndrome market. Amniocentesis or chorionic villus sampling (CVS) are available today with regards to this. These are the type of invasive tests to remove a sample of tissue or fluid so that it can be further tested for the presence of the extra copy of chromosome 13. All these factors are contributing in the growth of the market.
- Increasing Demand of Genetic Testing
The rising demand of genetic testing leads to the market expansion globally. Genetic testing is widely used to help parents plan for future pregnancies. The test results will lead to a more accurate assessment of the likelihood of the syndrome affecting future pregnancies.
Restraints/Challenges
- Lack of Awareness
The sales of potential products are not succeeding much due to the lack of awareness of the syndrome. Though effective treatments are available, but beliefs, poor inadequate communication between clinicians and patients, treatment adherence are the factors impeding the market growth.
- High Cost
与治疗过程相关的巨额支出阻碍了市场的增长。许多市场参与者投入巨额资金安装新的和先进的治疗程序以加快恢复过程，但成本却因此增加。
这份全球帕陶综合征市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关全球帕陶综合征市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。
全球帕陶综合征市场范围
全球帕陶综合征市场根据治疗、诊断、分销渠道和最终用户进行细分。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
诊断
- 超声波
- 无细胞 DNA 筛选
- 妊娠相关血浆蛋白 A 筛查
治疗
- 外科手术
- 疗法
终端用户
- 医院
- 研究机构
- 专科诊所
分销渠道
- 医院药房
- 零售药店
- 网上药店
- 其他的
全球帕陶综合征市场区域分析/见解
对全球帕陶综合征市场进行了分析，并按上述治疗、诊断、分销渠道和最终用户提供了市场规模洞察和趋势。
全球帕陶综合征市场报告涉及的主要国家 有：北美的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲其他地区、巴西、阿根廷和南美洲其他地区
由于产品主要制造商的存在，北美在预测期内占据市场主导地位，并且不断增加的研发活动和医疗保健支出有助于提高市场的显著增长。
由于对帕陶综合征市场的新研究和新开发的增加，亚太地区被认为将迎来最有利可图的时期。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外，在提供国家数据预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和全球帕陶综合征市场份额分析
全球帕陶综合征市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球帕陶综合征市场的关注有关
全球帕陶综合征市场的主要参与者包括：
- Centogene NV (德国)
- Eurofins Discovery（卢森堡）
- 霍夫曼-罗氏有限公司（瑞士）
- Invitae Corporation（美国）
- LLumina Inc（美国）
- Natera Inc（美国）
- PerkinElmer Inc（美国）
- Quest Diagnostics Incorporated（美国）
- Eurofins LifeCodexx GmbH（德国）
- Ravgen（美国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
